CELLMID LIMITED
Patent Owner
Stats
- 5 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Aug 24, 2017 most recent publication
Details
- 5 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 28 Total Citation Count
- Feb 10, 2000 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9023799 Method to reduce loss of cardiac function following ischemia/reperfusionDec 06, 05May 05, 15[A61K]
8288343 Activation of endothelial nitric oxide synthase by midkine and uses therefor in effecting vasodilationMar 28, 08Oct 16, 12[A61K]
8128934 Method for treatment or prevention of disease associated with functional disorder of regulatory T cellNov 14, 06Mar 06, 12[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.